The purpose of this study is to assess the effects of a complex telemedicine intervention as a part of an integrated care program for patients with chronic obstructive pulmonary disease (COPD) discharged from the hospital after disease exacerbation. Will be evaluated whether the intervention produces benefits in terms of mortality, reduction in hospital readmissions and health-related quality of life. In addition, the trial evaluates the economical and organizational impact of the new service and examines its acceptability by patients and health professionals.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Enrollment
380
Patients receive tailored intervention according to their clinical complexity. All patients in the intervention group receive: * Personalised care plan * Education on self-management * Access to a personalized online health folder * Access to Call center * Access to primary care and hospital specialists; follow-up visits for evaluation of clinical recovery and care plan adjustments (if needed). Patients with LOW complexity additionally receive: * Daily videoconferences for the 1st week after discharge * Remote monitoring for respiratory parameters. Sensors are selected on an individual basis by the medical specialists. Patients with HIGH complexity additionally receive: * Videoconferences for at least 1 month after discharge, scheduled on an individual basis. * Remote monitoring for respiratory parameters. * One monthly phone call from the call centre to promote and assess patient self-management.
Hospital Germans Trias i Pujol
Badalona, Catalonia, Spain
Capio Hospital Universitari Sagrat Cor
Barcelona, Catalonia, Spain
Hospital Clinic de Barcelona
Barcelona, Catalonia, Spain
Hospital del Mar
Barcelona, Catalonia, Spain
Hospital Plató
Barcelona, Catalonia, Spain
Hospital de Mataró
Mataró, Catalonia, Spain
Hospital Parc Taulí
Sabadell, Catalonia, Spain
Consorci Sanitari de Terrassa
Terrassa, Catalonia, Spain
Number of hospital readmissions
Time frame: 3 months period
Health related quality of life of the patients as measured by the SF-36 v2 questionnaire
Time frame: 3 months - at baseline and study end
Hospital anxiety and depression scale HADS
Time frame: 3 months - at baseline and study end
Lung condition as measured by FEV1
Time frame: 3 months - at baseline and study end
Condition-related health status measured by COPD Assessment Test (CAT)
Time frame: 3 months - at baseline and study end
Mortality
Time frame: 3 months period
Patients' Acceptance-Satisfaction measured by the WSD Questionnaire
Time frame: at the 3rd month of the telehealth intervention
Time in days to first readmission
Time frame: 3 months period
Length of stay in days for each readmission
Time frame: 3 months period
Number of emergency room visits
Time frame: at the 3rd month (end of trial)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.